ArticleFrontiers in artificial intelligence2026
AGMNet: an explainable gated multimodal framework integrating MRI heterogeneity and dopaminergic asymmetry for Parkinson's disease classification.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Parkinson's Disease (PD) is a neurological disorder that worsens over time and is marked by interhemispheric asymmetry, dopaminergic degeneration, and structural changes in the brain. Methods: This paper presents a novel approach: AGMNet- Adaptive Gated Multimodel Network, which is an explainable gated multimodal deep learning framework that combines structural magnetic resonance imaging (MRI), dopamine transporter (DaT) imaging, asymmetry-aware representations, and biomarker features for robust PD classification. The Grad-CAM method is incorporated with the proposed AGMNet framework to improve the model interpretability by identifying image regions that influence classification decisions. The performance of AGMNet framework was evaluated using five-fold cross-validation and compared with established deep learning architectures, including VGG16, VGG19, InceptionV3, and Xception. Results: The proposed AGMNet has achieved 0.8318 of accuracy, 0.8278 of balanced accuracy, sensitivity of 0.8556, specificity of 0.8000, AUC of 0.711, and Matthews correlation coefficient (MCC) of 0.6458. The proposed AGMNet model demonstrated competitive classification performance relative to the evaluated baseline architectures. The combination of DaT imaging, asymmetry-aware features, and biomarker representations in the proposed model, contributed more strongly to the fused representation than MRI features alone. Discussion: The findings indicate that adaptive multimodal fusion in the AGMNet framework can improve the integration of complementary structural, functional, asymmetry-related, and biomarker information for PD classification. The learned gate weights further demonstrate the relevance of functional and asymmetry-aware information within the proposed framework, while Grad-CAM provides additional insight into model decision-making. Therefore, the AGMNet framework offers a potentially useful and interpretable framework for multimodal PD classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.